National Association of Testing Authorities, Australia
Scope of Accreditation
Microbiological Diagnostic Unit, Public Health Laboratory - University of Melbourne
Site
The University of Melbourne – At the Peter Doherty Institute for Infection & Immunity
Accreditation No.
1019
Site No.
3284
Date of Accreditation
28 Oct 1991
Address
Department of Microbiology and Immunology, At the Peter Doherty Institute for Infection and Immunity, Level 1, 792 Elizabeth St (cnr of Grattan and Elizabeth St)
Melbourne, VIC 3000
Australia
Contact
Ms Selena Heaton P: +61 (03) 83445701
Availability
Services available to external clients
Supervision
S (Specialised)
Scope of Accreditation
The University of Melbourne – At the Peter Doherty Institute for Infection & Immunity
ISO 15189 (2022)
- This facility complies with the relevant National Pathology Accreditation Advisory Council (NPAAC) requirements.
Human Pathology
Medicare expiry date
04 Jul 2026
Last Activity Date
22 Apr 2024
| Service | Product | Determinant |
|---|---|---|
| Legal management - Forensic operations module | Materials defined by all or some for which the site is accredited | Case record review; Chain of custody; Control of records; Court testimony monitoring; Sample/evidence integrity; Security and access |
| Microbiology - Bacteriology - Detection of pathogenic bacteria | Axilla swabs; Bacterial isolates; Nasal swabs; Perineum swabs; Throat swabs | Staphylococcus aureus; Pathogenic identification |
| Bacterial isolates | Bacteria; Pathogenic identification | |
| Campylobacter spp.; Pathogenic identification and antibiotic susceptibility | ||
| Bacteria; Pathogenic identification | ||
| Antibiotic susceptibility | ||
| Antibiotic susceptibility | ||
| Neisseria gonorrhoeae; Neisseria meningitidis; Pathogenic identification and antibiotic susceptibility | ||
| Neisseria spp.; Streptococcus pyogenes; Pathogenic identification | ||
| Bacillus anthracis; Pathogenic identification | ||
| Aeromonas spp.; Brucella spp.; Burkholderia pseudomallei; Francisella tularensis; Haemophilus influenzae; Legionella spp.; Salmonella paratyphi; Salmonella spp.; Salmonella typhi; Shigella spp.; Vibrio spp.; Yersinia pestis; Yersinia spp.; Pathogenic identification | ||
| Bacterial isolates; Blood; Cerebrospinal fluid (CSF); Cutaneous swabs from vesicle or eschar; Faeces; Haemorrhagic fluid from nose, mouth or anus; Nasal swabs; Respiratory specimens; Sputum; Throat swabs | Bacillus anthracis; Pathogenic identification | |
| Bacterial isolates; Enema; Faeces; Gastric aspirate; Rectal swabs | Clostridium botulinum; Pathogenic identification | |
| Bacterial isolates; Faecal enrichment broth | Escherichia coli spp.; Pathogenic identification | |
| Bacterial isolates; Faeces; Rectal swabs; Urine; Wound swabs | Carbapenemase-producing Enterobacteriaceae (CPE); Pathogenic identification | |
| Bacterial isolates; Nasal swabs; Pharynx swabs; Throat swabs | Streptococcus pyogenes; Pathogenic identification | |
| Bacterial isolates; Nasal swabs; Throat swabs | Corynebacterium diphtheriae; Haemophilus influenzae; Neisseria meningitidis | |
| Bacterial isolates; Skin swabs; Throat swabs | Corynebacterium diphtheriae; Pathogenic identification | |
| Blood; Faeces; General swabs; Intestinal contents; Wound swabs | Bacillus anthracis; Pathogenic identification | |
| Faeces | Clostridioides difficile; Clostridioides difficile toxin; Pathogenic identification | |
| Campylobacter spp.; Escherichia coli - Enteroinvasive (EIEC); Escherichia coli - Pathogenic; Listeria monocytogenes; Shigella spp.; Staphylococcus aureus; Yersinia enterocolitica; Pathogenic identification | ||
| Faeces; Rectal swabs | Vibrio spp.; Pathogenic identification | |
| Faeces; Urine | Salmonella spp.; Pathogenic identification | |
| Faeces; Vomitus | Aeromonas spp.; Bacillus cereus; Clostridium perfringens; Escherichia coli - Shiga toxin-producing (STEC); Plesiomonas spp.; Pathogenic identification | |
| Microbiology - Environmental investigations and/or infection control (Clinical non-human testing) | Air; Blood transfusion bags; Dialysis waters; Environmental swabs; Gastrointestinal endoscopes; Microfilter discs; Spore strips; Vascular catheter tips; Waters | Detection and characterisation of organisms (including identification and typing); Organism characterisation for patient management; Pathogenic identification and antibiotic susceptibility |
| Microbiology - Molecular biology - Bioinformatic analysis | DNA sequences | Primary analysis - Conversion of instrument file to FASTQ or FASTA file; Secondary analysis - Alignment and variant calling; Tertiary analysis - Data annotation and interpretation |
| Microbiology - Molecular biology - Detection, characterisation and/or quantitation of microbial nucleic acids (bacteria) | Anal swab; Aptima diluent; Cervical swabs; Rectal swabs; Urine; Vaginal swabs | Chlamydia trachomatis L serovar |
| Anal swab; Aptima diluent; Cervical swabs; Urine; Vaginal swabs | Fluoroquinolone resistant Mycoplasma genitalium | |
| Anal swab; Cervical swabs; Rectal swabs; Urine; Vaginal swabs | Azithromycin resistant Mycoplasma genitalium; Macrolide resistant Mycoplasma genitalium | |
| Aptima diluent; Genital swabs; Rectal swabs; Urine; Vaginal swabs | Azithromycin resistant Mycoplasma genitalium | |
| Aspirates; Bacterial isolates; Blood; Cerebrospinal fluid (CSF) | Neisseria meningitidis; Neisseria meningitidis FetA VR typing; Neisseria meningitidis PorA; Neisseria meningitidis PorB | |
| Aspirates; Bacterial isolates; Blood; Cerebrospinal fluid (CSF); Eye swabs; Faeces; Genital swabs; Rectal swabs; Synovial fluid; Tissues; Urine; Wound swabs | Vibrio spp. rpoB gene; Vibrio spp. ompW gene; Vibrio spp. ctxA gene | |
| Bacillus anthracis; Brucella spp.; Burkholderia mallei; Burkholderia pseudomallei; Clostridium botulinum toxin genes; Coxiella burnetti; Francisella tularensis; Yersinia pestis | ||
| Aspirates; Bacterial isolates; Blood; Cerebrospinal fluid (CSF); Pleural fluid; Synovial fluid; Tissues | Haemophilus influenzae acsB gene; Haemophilus influenzae bcsB gene; Haemophilus influenzae bexD gene; Haemophilus influenzae ccsD gene; Haemophilus influenzae dcsE gene; Haemophilus influenzae escH gene; Haemophilus influenzae hpd gene; Neisseria meningitidis; Neisseria meningitidis ctrA gene; Neisseria meningitidis sacB gene; Neisseria meningitidis sodC gene; Neisseria meningitidis synD gene; Neisseria meningitidis synE gene; Neisseria meningitidis synF gene; Neisseria meningitidis synG gene; Neisseria meningitidis xcbB gene; Streptococcus pneumoniae lytA gene | |
| Bacterial isolates | Bacillus anthracis; Corynebacterium diphtheriae | |
| Listeria monocytogenes inlA gene; Listeria monocytogenes prfA gene | ||
| Carbapenemase resistance gene detection | ||
| Escherichia coli - Enteroinvasive (EIEC) ipaH gene; Klebsiella pneumoniae K1; Klebsiella pneumoniae K2; Klebsiella pneumoniae K5; Klebsiella pneumoniae magA gene; Klebsiella pneumoniae wzyF gene; Shigella spp. | ||
| Burkholderia spp. recA gene; Legionella spp. mip gene | ||
| Escherichia coli STEC stx1/stx2 | ||
| Bacterial isolates; Blood; Cerebrospinal fluid (CSF) | Streptococcus pneumoniae lytA gene; Streptococcus pneumoniae cpsA gene | |
| Listeria monocytogenes hly gene | ||
| Bacterial isolates; DNA extracts | Clostridium tetani toxin tetX gene | |
| Bacterial isolates; Enrichment broth | Escherichia coli ehx gene; Escherichia coli aea gene; Escherichia coli rfb gene; Escherichia coli wzx gene; Escherichia coli STEC stx1/stx2; Escherichia coli stx gene | |
| Cerebrospinal fluid (CSF) | Escherichia coli K1; Haemophilus influenzae; Listeria monocytogenes; Neisseria meningitidis - Encapsulated; Streptococcus agalactiae (Streptococcus group B); Streptococcus pneumoniae | |
| Faeces | Campylobacter coli; Campylobacter jejuni; Campylobacter spp.; Escherichia coli - Enteroinvasive (EIEC); Escherichia coli - Enterotoxigenic (ETEC); Escherichia coli K1; Escherichia coli STEC stx1/stx2; Plesiomonas shigelloides; Salmonella spp.; Shigella spp.; Vibrio cholerae; Vibrio parahaemolyticus; Vibrio spp.; Vibrio vulnificus; Yersinia enterocolitica; Shiga toxin; Toxin gene detection | |
| Campylobacter coli; Campylobacter jejuni; Campylobacter upsaliensis; Clostridium difficile toxin A; Clostridium difficile toxin B; Escherichia coli - Enteroaggregative (EAEC); Escherichia coli - Enteroinvasive (EIEC); Escherichia coli - Enteropathogenic (EPEC); Escherichia coli - Enterotoxigenic (ETEC); Escherichia coli STEC stx1/stx2; Plesiomonas shigelloides; Salmonella spp.; Vibrio parahaemolyticus; Vibrio vulnificus; Yersinia enterocolitica | ||
| Microbiology - Molecular biology - Detection, characterisation and/or quantitation of microbial nucleic acids (fungi) | Cerebrospinal fluid (CSF) | Cryptococcus gattii; Cryptococcus neoformans |
| Microbiology - Molecular biology - Detection, characterisation and/or quantitation of microbial nucleic acids (protozoan parasites) | Faeces | Cryptosporidium hominis; Cryptosporidium parvum; Entamoeba histolytica; Giardia lamblia |
| Cryptosporidium spp.; Entamoeba histolytica; Giardia lamblia | ||
| Cryptosporidium hominis; Cryptosporidium parvum; Cryptosporidium spp. | ||
| Microbiology - Molecular biology - Detection, characterisation and/or quantitation of microbial nucleic acids (viruses) | Cerebrospinal fluid (CSF) | Cytomegalovirus (CMV); Enterovirus; Herpes simplex virus type 1 (HSV1); Herpes simplex virus type 2 (HSV2); Human herpes virus type 6 (HHV6); Human parechovirus; Varicella zoster virus (VZV) |
| Faeces | Adenovirus; Astrovirus; Norovirus; Rotavirus; Sapovirus | |
| Adenovirus F40; Adenovirus F41; Astrovirus; Norovirus G1; Norovirus G2; Rotavirus A; Sapovirus I; Sapovirus II; Sapovirus IV; Sapovirus V | ||
| Nasal swabs; Nasopharyngeal swabs; Oropharyngeal swabs | Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, COVID) | |
| Microbiology - Molecular biology - Microbial DNA and/or RNA extraction | Bacterial isolates; Blood; Cerebrospinal fluid (CSF); Eye swabs; Faeces; Fluids; Genital swabs; Rectal swabs; Tissues; Urine | Viable DNA; Viable DNA for sequencing; Viable DNA for whole genome sequencing; Viable RNA; Viable RNA for sequencing |
| Microbiology - Molecular biology - Microbial DNA and/or RNA sequencing | Bacterial isolates; Extracted DNA; Extracted RNA; Purified PCR product | RNA sequence analysis; Sequenced DNA by Sanger sequencing; Sequenced DNA utilising massively parallel sequencing technologies |
| Microbiology - Molecular biology - Microbial genotyping by whole genome sequencing studies | Bacterial isolates | Bacteria |
| Microbiology - Molecular biology - Public health investigation and/or monitoring | Amniotic fluid; Aspirates; Bacterial isolates; Blood; Bronchial swabs; Bronchial washings; Bronchoalveolar lavage; Cerebrospinal fluid (CSF); Cervical specimen; Cervical swabs; Dry swabs; Eye swabs; Faeces; Genital swabs; Human clinical samples; Liquid based cytology specimens; Nasal swabs; Nasopharyngeal aspirate; Nasopharyngeal swabs; Non-human clinical isolates; Paraffin embedded tissue; Pericardial fluid; Plasma; Pleural fluid; Rectal swabs; Respiratory specimens; Semen; Serum; Sputum; Sterile site; Tampons; Throat swabs; Tissues; Tonsil swabs; Urethral swabs; Urine; Vaginal swabs; Wound swabs | Detection and characterisation of organisms (including identification and typing); Organism characterisation for patient management; Organisms of public health significance |
| Microbial nucleic acids | Phylogenetic analysis | |
| Microbiology - Serology of infection - Microbial antibody and/or antigen detection and/or quantitation | Broth cultures; Faeces | Clostridium perfringens enterotoxin |
| Faeces; Rectal swabs | Cryptosporidium parvum; Cryptosporidium antigen; Giardia lamblia; Giardia antigen | |
| Plasma; Serum | Clostridium tetani IgG antibody; Corynebacterium diphtheriae IgG antibody; Entamoeba histolytica; Yersinia spp. IgG antibody; Yersinia spp. | |
| Microbiology - Serology of infection - Microbial typing | Bacterial isolates | Streptococcus pneumoniae |
| Bacterial isolates; Broth cultures | Escherichia coli spp.; Neisseria meningitidis; Neisseria meningitidis - Encapsulated; Neisseria meningitidis polysaccharide capsule antigen; Salmonella spp. O/H antigens |
Mobile Testing
ISO 15189 (2022)
Human Pathology
Medicare expiry date
04 Jul 2026
Last Activity Date
22 Apr 2024
| Service | Product | Determinant |
|---|---|---|
| Microbiology - Molecular biology - Detection, characterisation and/or quantitation of microbial nucleic acids (viruses) | Nasal swabs; Nasopharyngeal swabs | Influenza A virus; Influenza B virus; Respiratory syncytial virus (RSV); Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2, COVID) |
The only data displayed is that deemed relevant and necessary for the clear description of the activities and services covered by the scope of accreditation.
Grey text appearing in a SoA is additional freetext providing further refinement or information on the data in the preceding line entry.
Accreditation No.
1019
Site No.
3284
Print date
30 Apr 2025
END OF SCOPE